Of note, inactivation of STAT3 in regulatory B-cells reduces IL10 and TGFβ production, and augments anti-tumor immunity by enhancing cytotoxic T-cell activity and by decreasing the number of Tregs in draining lymph nodes and tumor tissues [126]. This evidence concerns the gene STAT3 and neoplasm.